{"id":9129,"date":"2026-09-30T18:01:30","date_gmt":"2026-09-30T17:01:30","guid":{"rendered":"https:\/\/wheat-quail-856400.hostingersite.com\/?p=9129"},"modified":"2026-10-20T10:41:28","modified_gmt":"2026-10-20T09:41:28","slug":"cpd-plasma-vs-citrate-plasma","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/cpd-plasma-vs-citrate-plasma\/","title":{"rendered":"CPD- vs. Citratplasma"},"content":{"rendered":"<!-- ============================================================\n   SeamlessBio Blog Post \u2014 sb-bp Format\n   Slug:        cpd-plasma-vs-citrate-plasma\n   SEO Title:   CPD Plasma vs. Citrate Plasma: Key Differences         (48 chars \u2713)\n   Meta Desc:   CPD and citrate plasma differ in anticoagulant composition, matrix effects and regulatory fit. This guide explains which to use for IVD validation. (151 chars \u2713)\n   Keyphrase:   CPD plasma vs citrate plasma\n   Int. links:  \/human-plasma-apheresis-plasma\/ \u00b7 \/human-plasma-pooled\/ \u00b7 \/cpd-plasma-shortage-citrate-apheresis-plasma-ivd-validation\/ \u00b7 \/contact\/\n   Note: shorter, focused comparison guide \u2014 complements the CPD shortage post\n   ============================================================ -->\n\n\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"BreadcrumbList\",\n  \"@id\": \"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#breadcrumb\",\n  \"itemListElement\": [\n    {\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/seamlessbio.de\/\"},\n    {\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blog\",\"item\":\"https:\/\/seamlessbio.de\/blog\/\"},\n    {\"@type\":\"ListItem\",\"position\":3,\"name\":\"CPD Plasma vs. Citrate Plasma: Key Differences\",\"item\":\"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/\"}\n  ]\n}\n<\/script>\n\n\n\n<style>\n.sb-bppl1-hero{background:linear-gradient(135deg,#18b7b2 0%,#0d9490 100%);border-radius:12px;padding:48px 40px;margin-bottom:36px}\n.sb-bppl1-hero h1{color:#fff!important;font-size:2rem;font-weight:700;line-height:1.25;margin:0 0 14px 0}\n.sb-bppl1-hero .meta{font-size:.8rem;color:rgba(255,255,255,.75)!important;margin:0 0 18px 0;text-transform:uppercase;letter-spacing:.03em}\n.sb-bppl1-hero p{color:rgba(255,255,255,.95)!important;font-size:1.1rem;line-height:1.65;max-width:720px;margin:0}\n.sb-bppl1-card{background:#fff;border:1px solid #e8f7f7;border-radius:10px;padding:36px 40px;margin-bottom:28px}\n.sb-bppl1-card h2{font-size:1.35rem;font-weight:700;color:#0e1c2a;margin:0 0 16px 0}\n.sb-bppl1-card h3{font-size:1.05rem;font-weight:600;color:#18b7b2;margin:22px 0 10px 0}\n.sb-bppl1-card p{color:#374151;line-height:1.7;margin:0 0 14px 0}\n.sb-bppl1-card p:last-child{margin-bottom:0}\n.sb-bppl1-hl{background:#f0faf9;border-left:4px solid #18b7b2;border-radius:0 8px 8px 0;padding:20px 24px;margin:24px 0;color:#1a3a3a;line-height:1.65}\n.sb-bppl1-hl strong{color:#0d9490}\n.sb-bppl1-table-wrap{overflow-x:auto;margin:16px 0}\n.sb-bppl1-table{width:100%;border-collapse:collapse;font-size:.92rem}\n.sb-bppl1-table th{background:#18b7b2;color:#fff!important;padding:11px 16px;text-align:left;font-weight:600}\n.sb-bppl1-table td{padding:10px 16px;border-bottom:1px solid #e8f7f7;color:#374151;vertical-align:top}\n.sb-bppl1-table tr:nth-child(even) td{background:#f4fefe}\n.sb-bppl1-ok{color:#18b7b2;font-weight:600}\n.sb-bppl1-warn{color:#e07a00;font-weight:600}\n.sb-bppl1-bad{color:#e05252;font-weight:600}\n.sb-bppl1-cta{background:#18b7b2;border-radius:12px;padding:40px;text-align:center;margin-bottom:28px}\n.sb-bppl1-cta h2{color:#fff!important;font-size:1.5rem;font-weight:700;margin:0 0 12px 0}\n.sb-bppl1-cta p{color:rgba(255,255,255,.9)!important;margin:0 0 24px 0}\n.sb-bppl1-cta a.btn{display:inline-block;background:#fff;color:#18b7b2!important;font-weight:700;padding:14px 32px;border-radius:8px;text-decoration:none;font-size:1rem;margin:0 8px 8px 8px}\n.sb-bppl1-cta a.btn:hover{opacity:.88}\n.sb-bppl1-cta a.outline{background:transparent;color:#fff!important;border:2px solid rgba(255,255,255,.8)}\n.sb-bppl1-faq{margin-bottom:28px}\n.sb-bppl1-faq h2{font-size:1.35rem;font-weight:700;color:#0e1c2a;margin:0 0 20px 0}\n.sb-bppl1-faq details{border:1px solid #e8f7f7;border-radius:8px;margin-bottom:10px}\n.sb-bppl1-faq summary{background:#f9fdfd;padding:16px 44px 16px 20px;font-weight:600;color:#0e1c2a;cursor:pointer;list-style:none;position:relative}\n.sb-bppl1-faq summary::after{content:\"+\";position:absolute;right:20px;top:50%;transform:translateY(-50%);font-size:1.3rem;color:#18b7b2;font-weight:300}\n.sb-bppl1-faq details[open] summary::after{content:\"\u2212\"}\n.sb-bppl1-faq details[open] summary{background:#e8f7f7}\n.sb-bppl1-faq .body{padding:16px 20px;color:#374151;line-height:1.7}\n@media(max-width:680px){.sb-bppl1-hero{padding:32px 20px}.sb-bppl1-hero h1{font-size:1.55rem}.sb-bppl1-card{padding:24px 20px}.sb-bppl1-cta{padding:28px 20px}}\n<\/style>\n<div class=\"sb-bppl1-hero\">\n  <p class=\"meta\">Blog \u00b7 Human Plasma \u00b7 IVD \u00b7 October 2026 \u00b7 5 min read<\/p>\n  <h1>CPD Plasma vs. Citrate Plasma: Key Differences Explained<\/h1>\n  <p>CPD and citrate plasma are both anticoagulated with citrate \u2014 but they are not the same matrix. The additional components in CPD solution introduce measurable differences in plasma composition that matter for IVD validation, immunoassay development, and DMPK protein binding studies. Here is a clear breakdown.<\/p>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">What Is CPD Plasma?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CPD plasma is collected using Anticoagulant Citrate Phosphate Dextrose (CPD) solution \u2014 a mixture of four components in fixed proportions: sodium citrate (anticoagulant), citric acid (pH buffer), monobasic sodium phosphate (buffer and stabiliser), and dextrose (glucose, for red cell preservation during whole blood storage). The CPD solution is present at a 1:7 ratio to whole blood volume in standard collection bags.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After centrifugation of the whole blood unit, the cellular fraction is removed and the remaining plasma \u2014 now containing CPD anticoagulant \u2014 is collected. This is CPD plasma.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Is Citrate Plasma?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Citrate plasma is anticoagulated with sodium citrate only \u2014 typically at 3.2% (0.109 mol\/L) or 3.8% (0.129 mol\/L), added to whole blood or collected via apheresis at a 1:9 citrate:blood ratio. No phosphate, no dextrose. The citrate chelates calcium ions, preventing coagulation cascade activation, while leaving plasma composition otherwise unmodified.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Citrate plasma is the standard anticoagulant for coagulation testing (PT, APTT, fibrinogen, factor activity assays) and is widely used in DMPK protein binding assays and IVD validation as a cleaner alternative to CPD.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Side-by-Side Comparison<\/h2>\n\n\n\n<div class=\"sb-bppl1-table-wrap\">\n  <table class=\"sb-bppl1-table\">\n    <thead>\n      <tr><th>Parameter<\/th><th>CPD Plasma<\/th><th>Sodium Citrate Plasma (3.2%\/3.8%)<\/th><\/tr>\n    <\/thead>\n    <tbody>\n      <tr><td><strong>Anticoagulant<\/strong><\/td><td>Sodium citrate + citric acid + NaH\u2082PO\u2084 + dextrose<\/td><td>Sodium citrate only<\/td><\/tr>\n      <tr><td><strong>Anticoagulant:blood ratio<\/strong><\/td><td>1:7 (fixed by bag volume)<\/td><td>1:9 (standard for 3.2%)<\/td><\/tr>\n      <tr><td><strong>Glucose level in plasma<\/strong><\/td><td class=\"sb-bppl1-warn\">Elevated ~20\u201325 mM above physiological level (from dextrose)<\/td><td class=\"sb-bppl1-ok\">Physiological \u2014 no added glucose<\/td><\/tr>\n      <tr><td><strong>Phosphate content<\/strong><\/td><td class=\"sb-bppl1-warn\">Elevated \u2014 additional inorganic phosphate from NaH\u2082PO\u2084<\/td><td class=\"sb-bppl1-ok\">Physiological \u2014 no additional phosphate<\/td><\/tr>\n      <tr><td><strong>Free calcium<\/strong><\/td><td>Chelated by citrate \u2014 not available for coagulation<\/td><td>Chelated by citrate \u2014 reversible by adding CaCl\u2082<\/td><\/tr>\n      <tr><td><strong>Protein composition<\/strong><\/td><td>Physiological \u2014 all plasma proteins present<\/td><td>Physiological \u2014 all plasma proteins present<\/td><\/tr>\n      <tr><td><strong>Coagulation factors<\/strong><\/td><td class=\"sb-bppl1-ok\">Preserved if frozen rapidly<\/td><td class=\"sb-bppl1-ok\">Preserved; preferred format for coagulation assays<\/td><\/tr>\n      <tr><td><strong>Collection route<\/strong><\/td><td>Whole blood donation only<\/td><td>Whole blood or apheresis<\/td><\/tr>\n      <tr><td><strong>Glucose-sensitive assays<\/strong><\/td><td class=\"sb-bppl1-bad\">Not suitable \u2014 elevated glucose artefact<\/td><td class=\"sb-bppl1-ok\">Suitable<\/td><\/tr>\n      <tr><td><strong>Phosphate-sensitive assays<\/strong><\/td><td class=\"sb-bppl1-warn\">Potential interference \u2014 check assay dependency<\/td><td class=\"sb-bppl1-ok\">No concern<\/td><\/tr>\n      <tr><td><strong>DMPK protein binding assays<\/strong><\/td><td class=\"sb-bppl1-warn\">Usable but dextrose can affect drug partitioning in some systems<\/td><td class=\"sb-bppl1-ok\">Preferred \u2014 cleaner matrix<\/td><\/tr>\n      <tr><td><strong>IVD calibrator \/ control matrix<\/strong><\/td><td>Historically used; supply is declining<\/td><td class=\"sb-bppl1-ok\">Current best-practice alternative<\/td><\/tr>\n      <tr><td><strong>Supply outlook (EU)<\/strong><\/td><td class=\"sb-bppl1-bad\">Tightening \u2014 structural decline<\/td><td class=\"sb-bppl1-ok\">Stable and growing with apheresis<\/td><\/tr>\n    <\/tbody>\n  <\/table>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">The Dextrose Issue: Why It Matters More Than It Sounds<\/h2>\n\n\n\n<div class=\"sb-bppl1-card\">\n  <p>The dextrose in CPD solution adds approximately 20\u201325 mmol\/L of glucose to the plasma matrix above the normal physiological range (approximately 4\u20136 mmol\/L fasting). This elevated glucose level is invisible on a standard CoA \u2014 it is not reported as an anomaly because it is an expected feature of the CPD matrix, not a quality failure.<\/p>\n  <p>For most immunoassay and haematology applications, this glucose elevation is irrelevant. But for specific assay types, it is a significant matrix interference:<\/p>\n  <h3>Glucose assays<\/h3>\n  <p>Any assay measuring plasma glucose \u2014 clinical chemistry glucose methods, glucose oxidase-based ELISA \u2014 will return artificially high values in CPD plasma. CPD plasma cannot be used as a calibrator or control matrix for glucose measurement.<\/p>\n  <h3>Enzyme activity assays<\/h3>\n  <p>Some enzymes involved in glycolysis or phosphate metabolism show altered activity in the elevated glucose\/phosphate environment of CPD plasma. If your assay measures enzyme activity directly, validate the matrix effect specifically.<\/p>\n  <h3>DMPK plasma protein binding (PPB)<\/h3>\n  <p>In plasma protein binding studies using equilibrium dialysis or rapid equilibrium dialysis (RED assay), the elevated glucose and phosphate in CPD plasma can subtly alter the osmotic environment and potentially affect drug-protein binding equilibria for compounds with narrow binding constants. Citrate plasma is the cleaner matrix for PPB work.<\/p>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\">When CPD, When Citrate \u2014 Quick Reference<\/h2>\n\n\n\n<div class=\"sb-bppl1-table-wrap\">\n  <table class=\"sb-bppl1-table\">\n    <thead>\n      <tr><th>Application<\/th><th>Recommended Matrix<\/th><th>Reason<\/th><\/tr>\n    <\/thead>\n    <tbody>\n      <tr><td>General immunoassay validation (troponin, CRP, ferritin, hormones)<\/td><td class=\"sb-bppl1-ok\">Citrate plasma<\/td><td>Cleaner matrix; no glucose or phosphate artefact; better supply<\/td><\/tr>\n      <tr><td>Coagulation assays (PT, APTT, fibrinogen, factor activity)<\/td><td class=\"sb-bppl1-ok\">Citrate plasma 3.2%<\/td><td>Industry and regulatory standard; calcium reversibility required<\/td><\/tr>\n      <tr><td>DMPK plasma protein binding<\/td><td class=\"sb-bppl1-ok\">Citrate plasma<\/td><td>Physiological matrix; avoids glucose interference<\/td><\/tr>\n      <tr><td>Glucose or glycaemic assay validation<\/td><td class=\"sb-bppl1-bad\">Not CPD \u2014 use citrate or EDTA<\/td><td>CPD dextrose invalidates glucose measurement<\/td><\/tr>\n      <tr><td>IVD calibrator manufacturing (large bulk lots)<\/td><td class=\"sb-bppl1-ok\">Apheresis citrate plasma<\/td><td>Larger individual lot volumes, better consistency, stable supply<\/td><\/tr>\n      <tr><td>Haematology method validation (where plasma is the matrix)<\/td><td>Either \u2014 validate per method<\/td><td>Check anticoagulant interference with specific analyte<\/td><\/tr>\n    <\/tbody>\n  <\/table>\n<\/div>\n\n\n\n<div class=\"sb-bppl1-hl\">\n  <strong>Switching from CPD to citrate plasma?<\/strong> Read our companion post: <a href=\"https:\/\/seamlessbio.de\/cpd-plasma-shortage-citrate-apheresis-plasma-ivd-validation\/\" style=\"color:#0d9490;font-weight:600;\">CPD Plasma Is Getting Scarce \u2014 Why IVD Labs Are Switching to Citrate and Apheresis Plasma<\/a> \u2014 covering the supply situation, the transition process, and IVDR implications in detail.\n<\/div>\n\n\n\n<div class=\"sb-bppl1-cta\">\n  <h2>Citrate Plasma (3.2% \/ 3.8%) \u2014 EU Origin, Available Now<\/h2>\n  <p>Pooled and single-donor sodium citrate plasma, apheresis volumes and ACD-A format \u2014 from certified EU donor centres, shipped from Germany. Full CoA per lot. No minimum order quantity.<\/p>\n  <a href=\"https:\/\/seamlessbio.de\/human-plasma-apheresis-plasma\/\" class=\"btn\">View Citrate Plasma<\/a>\n  <a href=\"https:\/\/seamlessbio.de\/contact\/\" class=\"btn outline\">Request a Sample Lot<\/a>\n<\/div>\n\n\n\n<div class=\"sb-bppl1-faq\">\n  <h2>Frequently Asked Questions<\/h2>\n  <details><summary>Are CPD plasma and citrate plasma interchangeable for IVD validation?<\/summary><div class=\"body\">They are partially interchangeable for applications where glucose and phosphate levels are not relevant to the analyte. For immunoassays measuring proteins, antibodies or non-metabolic analytes, citrate plasma is a suitable replacement. For glucose assays, metabolic analytes, or enzyme activity assays where the elevated CPD matrix components are relevant, they are not interchangeable without a bridging study. A matrix comparison experiment is always recommended before substituting one for the other in a validated method.<\/div><\/details>\n  <details><summary>What is the glucose concentration difference between CPD plasma and citrate plasma?<\/summary><div class=\"body\">Standard whole-blood plasma has a physiological glucose concentration of approximately 4\u20136 mmol\/L in a fasting state. The dextrose component of CPD solution adds approximately 20\u201325 mmol\/L of glucose to the plasma matrix, bringing the total glucose level in CPD plasma to well above the physiological range. Sodium citrate plasma contains only the glucose naturally present in the donor&#8217;s blood at the time of collection.<\/div><\/details>\n  <details><summary>Does switching from CPD to citrate plasma require revalidation?<\/summary><div class=\"body\">Yes \u2014 a matrix change triggers a change control requirement under IVDR and Good Manufacturing Practice for IVD manufacturers. A bridging study comparing key assay performance metrics (accuracy, precision, linearity, interference) in both matrices is required to support the change in your technical documentation. For assays where glucose and phosphate do not affect the analyte, bridging data is typically sufficient without a full revalidation. See our detailed guide on the CPD to citrate plasma transition for a full checklist.<\/div><\/details>\n  <details><summary>Can I use ACD-A plasma instead of citrate plasma?<\/summary><div class=\"body\">ACD-A (Anticoagulant Citrate Dextrose Formula A) also contains citrate and dextrose \u2014 like CPD, it introduces elevated glucose into the plasma matrix, though at a different ratio. ACD-A is primarily used for platelet apheresis and leukapheresis. For IVD validation and DMPK applications where glucose is a concern, sodium citrate plasma (3.2% or 3.8%) is the cleaner choice. ACD-A plasma is appropriate for specific cell therapy and platelet-related applications where it is the established anticoagulant.<\/div><\/details>\n<\/div>\n\n\n\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\"@type\":\"Question\",\"name\":\"Are CPD plasma and citrate plasma interchangeable for IVD validation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"They are partially interchangeable for applications where glucose and phosphate levels are not relevant to the analyte. For glucose assays or enzyme activity assays affected by the CPD matrix components, they are not interchangeable without a bridging study.\"}},\n    {\"@type\":\"Question\",\"name\":\"What is the glucose concentration difference between CPD plasma and citrate plasma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CPD solution adds approximately 20\u201325 mmol\/L of glucose to plasma matrix above the physiological range of 4\u20136 mmol\/L. Sodium citrate plasma contains only the glucose naturally present in the donor's blood.\"}},\n    {\"@type\":\"Question\",\"name\":\"Does switching from CPD to citrate plasma require revalidation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes \u2014 a matrix change triggers a change control requirement under IVDR. A bridging study comparing key assay performance metrics in both matrices is required. For assays where glucose and phosphate do not affect the analyte, bridging data is typically sufficient without full revalidation.\"}},\n    {\"@type\":\"Question\",\"name\":\"Can I use ACD-A plasma instead of citrate plasma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ACD-A also contains citrate and dextrose, introducing elevated glucose like CPD. For IVD validation and DMPK applications where glucose is a concern, sodium citrate plasma (3.2% or 3.8%) is the cleaner choice.\"}}\n  ]\n}\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>Blog \u00b7 Human Plasma \u00b7 IVD \u00b7 October 2026 \u00b7 5 min read CPD Plasma vs. Citrate Plasma: Key Differences Explained CPD and citrate plasma are both anticoagulated with citrate \u2014 but they are not the same matrix. The additional components in CPD solution introduce measurable differences in plasma composition that matter for IVD validation, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_templately_pack_id":"","_templately_imported_at":"","_templately_source":"","_templately_import_session_id":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-9129","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CPD Plasma vs. Citrate Plasma: Key Differences<\/title>\n<meta name=\"description\" content=\"CPD and citrate plasma differ in anticoagulant composition, matrix effects and regulatory fit. This guide explains which to use for IVD validation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/cpd-plasma-vs-citrate-plasma\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CPD Plasma vs. Citrate Plasma: Key Differences\" \/>\n<meta property=\"og:description\" content=\"CPD and citrate plasma differ in anticoagulant composition, matrix effects and regulatory fit. This guide explains which to use for IVD validation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/cpd-plasma-vs-citrate-plasma\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-30T17:01:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-20T09:41:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046.png\" \/>\n\t<meta property=\"og:image:width\" content=\"973\" \/>\n\t<meta property=\"og:image:height\" content=\"288\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/380871817f00a1e16eccbe7585a20c17\"},\"headline\":\"CPD vs. Citrate Plasma\",\"datePublished\":\"2026-09-30T17:01:30+00:00\",\"dateModified\":\"2026-10-20T09:41:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/\"},\"wordCount\":1125,\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/\",\"name\":\"CPD Plasma vs. Citrate Plasma: Key Differences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-09-30T17:01:30+00:00\",\"dateModified\":\"2026-10-20T09:41:28+00:00\",\"description\":\"CPD and citrate plasma differ in anticoagulant composition, matrix effects and regulatory fit. This guide explains which to use for IVD validation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/seamlessbio.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/seamlessbio.de\\\/category\\\/uncategorized\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CPD vs. Citrate Plasma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Human serum, plasma and hPL, single-use bioprocessing bags, serum-free media, animal sera and FBS. EU stock, lot reservation up to 36 months, no minimum order.\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"Place\",\"ProfessionalService\"],\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#local-main-organization-logo\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/seamlessbio\\\/\",\"https:\\\/\\\/seamlessbio.ch\\\/\"],\"address\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#local-main-place-address\"},\"telephone\":[\"+49 (851) 37932226\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+49 (851) 37932226\",\"email\":\"info@seamlessbio.de\"},\"openingHoursSpecification\":[{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\"],\"opens\":\"09:00\",\"closes\":\"17:00\"},{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"00:00\"}],\"email\":\"info@seamlessbio.de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/380871817f00a1e16eccbe7585a20c17\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/seamlessbio.de\"],\"url\":\"https:\\\/\\\/seamlessbio.de\\\/de\\\/author\\\/admin\\\/\"},{\"@type\":\"PostalAddress\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#local-main-place-address\",\"streetAddress\":\"Dr.-Ernst-Derra-Str. 4\",\"addressLocality\":\"Passau\",\"postalCode\":\"94036\",\"addressRegion\":\"Bavaria\",\"addressCountry\":\"DE\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cpd-plasma-vs-citrate-plasma\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"width\":973,\"height\":288,\"caption\":\"SeamlessBio\"}]}<\/script>\n<meta name=\"geo.placename\" content=\"Passau\" \/>\n<meta name=\"geo.region\" content=\"Deutschland\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CPD-Plasma vs. Citratplasma: die wichtigsten Unterschiede","description":"CPD- und Citratplasma unterscheiden sich in der Zusammensetzung des Antikoagulans, in Matrixeffekten und in der regulatorischen Eignung. Dieser Leitfaden erkl\u00e4rt, welches Plasma sich f\u00fcr die IVD-Validierung eignet.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/cpd-plasma-vs-citrate-plasma\/","og_locale":"de_DE","og_type":"article","og_title":"CPD Plasma vs. Citrate Plasma: Key Differences","og_description":"CPD and citrate plasma differ in anticoagulant composition, matrix effects and regulatory fit. This guide explains which to use for IVD validation.","og_url":"https:\/\/seamlessbio.de\/de\/cpd-plasma-vs-citrate-plasma\/","og_site_name":"SeamlessBio","article_published_time":"2026-09-30T17:01:30+00:00","article_modified_time":"2026-10-20T09:41:28+00:00","og_image":[{"width":973,"height":288,"url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"admin","Gesch\u00e4tzte Lesezeit":"5\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#article","isPartOf":{"@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/"},"author":{"name":"admin","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/380871817f00a1e16eccbe7585a20c17"},"headline":"CPD vs. Citrate Plasma","datePublished":"2026-09-30T17:01:30+00:00","dateModified":"2026-10-20T09:41:28+00:00","mainEntityOfPage":{"@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/"},"wordCount":1125,"publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/","url":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/","name":"CPD-Plasma vs. Citratplasma: die wichtigsten Unterschiede","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-09-30T17:01:30+00:00","dateModified":"2026-10-20T09:41:28+00:00","description":"CPD- und Citratplasma unterscheiden sich in der Zusammensetzung des Antikoagulans, in Matrixeffekten und in der regulatorischen Eignung. Dieser Leitfaden erkl\u00e4rt, welches Plasma sich f\u00fcr die IVD-Validierung eignet.","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/seamlessbio.de\/"},{"@type":"ListItem","position":2,"name":"Uncategorized","item":"https:\/\/seamlessbio.de\/category\/uncategorized\/"},{"@type":"ListItem","position":3,"name":"CPD vs. Citrate Plasma"}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Humanserum, Plasma und hPL, Single-Use-Bioprozessbeutel, serumfreie Medien, Tierseren und FKS. EU-Lager, Chargenreservierung bis 36 Monate, ohne Mindestmenge.","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","Place","ProfessionalService"],"@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#local-main-organization-logo"},"image":{"@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#local-main-organization-logo"},"sameAs":["https:\/\/www.linkedin.com\/company\/seamlessbio\/","https:\/\/seamlessbio.ch\/"],"address":{"@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#local-main-place-address"},"telephone":["+49 (851) 37932226"],"contactPoint":{"@type":"ContactPoint","telephone":"+49 (851) 37932226","email":"info@seamlessbio.de"},"openingHoursSpecification":[{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday"],"opens":"09:00","closes":"17:00"},{"@type":"OpeningHoursSpecification","dayOfWeek":["Saturday","Sunday"],"opens":"00:00","closes":"00:00"}],"email":"info@seamlessbio.de"},{"@type":"Person","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/380871817f00a1e16eccbe7585a20c17","name":"admin","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/seamlessbio.de"],"url":"https:\/\/seamlessbio.de\/de\/author\/admin\/"},{"@type":"PostalAddress","@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#local-main-place-address","streetAddress":"Dr.-Ernst-Derra-Str. 4","addressLocality":"Passau","postalCode":"94036","addressRegion":"Bavaria","addressCountry":"DE"},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/cpd-plasma-vs-citrate-plasma\/#local-main-organization-logo","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","width":973,"height":288,"caption":"SeamlessBio"}]},"geo.placename":"Passau","geo.region":"Deutschland"},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/9129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=9129"}],"version-history":[{"count":1,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/9129\/revisions"}],"predecessor-version":[{"id":9130,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/9129\/revisions\/9130"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=9129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/categories?post=9129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/tags?post=9129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}